|
|
|
|
|
|
| Malignant Mixed Mesodermal Tumor |
| Etiology • Unknown |
| Pathogenesis • unknown • some cases associated with endometriosis, |
| Epidemiology • Post-menopausal women • Low parity • Rare neoplasm |
| General Gross Description • Large variegated lesions with areas of necrosis and hemorrhage • May have adhesions |
| General Microscopic Description • epithelial component most often serous or endometrioid with focal squamous differentiation • stroma may be spindle cell or show cartilage, skeletal muscle, smooth muscle or other soft tissue differentiation |
| Clinical Correlation • 2-3% of ovarian neoplasms • Post-menopausal women • Usually has spread in the peritoneal cavity at surgery • Debulking and chemotherapy utilized |
| References • Le T,Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.Gynecol Oncol 65(2), 237-240(1997) • Dictor M, Malignant mixed mesodermal tumor of the ovary: a reportof 22 cases. Obstet Gynecol 65(5), 720-724 (1985) |
| Malignant Mixed Mesodermal Tumor |
| Synopsis by: Melinda Sanders M.D. (T87000M89513)[255] |
| Search Medline at National Library of Medicine Please be patient during transfer. Medline will open in a new window. To return, close the Medline Window |
|
|
|
|
|
|